Tae Hwan Ms Kim

Tae Hwan Ms Kim

Auto-generated profile, based on publicly available information

Tae Hwan Ms Kim

Department of Pediatrics, College of Korean Medicine, Kyung Hee University, Kyung Hee University Medical Center, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2025 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
BLBoram Lee
Boram Lee
GCGyu Tae Chang
Gyu Tae Chang
HLHyelim Lee
Hyelim Lee
Sun Haeng LeeSun Haeng Lee
Sun Haeng Lee
TKTae Hwan Kim
Tae Hwan Kim
MSMi Ju Son
Mi Ju Son
Allergic rhinitis is a prevalent immune disorder with a significant impact on quality of life and socioeconomic burden. Korean Medicine treatments such as herbal medicine and acupuncture are widely utilized for allergic rhinitis due to clinical effectiveness and patient preferences. In particular, herbal decoctions, a key component of Korean Medicine treatment for allergic rhinitis, offer personalized treatment but pose challenges for randomized controlled trials due to the difficulty of placebo development. This study aims to establish a registry utilizing real-world data (RWD) on Korean Medicine treatment for allergic rhinitis, focusing on the effectiveness, safety, and cost-effectiveness of herbal decoctions in clinical practice. The KOrean medicine REgistry for Allergic rhinitis in Real-world settings (KOREA-R) aims to enroll 400 patients with allergic rhinitis receiving Korean Medicine treatment at two Korean Medicine hospitals from February 2025 to June 2028. Patients will be examined in three visits at 2-week intervals, followed by two additional online follow-ups at 6 and 12 months after week 4. RWD on symptom severity, quality of life, treatment administration and compliance, adverse events, and laboratory blood tests will be collected. Participation is voluntary, with no restrictions on treatment types or dosages. Statistical analyses, including propensity score matching and difference-in-difference, will be used to evaluate the effectiveness, safety, and cost-effectiveness of Korean Medicine treatment, particularly herbal decoctions. Data management ensures confidentiality and quality through a validated electronic data capture system and regular monitoring. The findings of KOREA-R will provide insights into the effectiveness and safety of Korean Medicine treatment for allergic rhinitis, with a focus on herbal decoctions tailored to individual patient symptoms and pattern identifications. Additionally, by systematically collecting RWD for multidimensional analysis, KOREA-R will offer valuable information on the cost-utility and cost-effectiveness of herbal decoctions for both patients and healthcare policymakers. Clinical Research Information Service, KCT0010133 (Registration date: January 13, 2025).

20 February 2026 in Medicine
Verified
Journal Article
Open access
SCSeo Yeon Kmd Choi
Seo Yeon Kmd Choi
TKTae Hwan Ms Kim
Tae Hwan Ms Kim
JHJu Hui Ms Han
Ju Hui Ms Han
MBMi Ran PhD Bang
Mi Ran PhD Bang
GCGyu Tae Chang
Gyu Tae Chang
Sun Haeng LeeSun Haeng Lee
Sun Haeng Lee
Given the limitations of conventional antiepileptic drugs and the growing need for complementary approaches, traditional Korean medicine has gained interest as a potential treatment option for pediatric and adolescent epilepsy. However, real-world clinical data on its use and safety remain limited. This exploratory study aimed to retrospectively investigate the real-world clinical use and safety of traditional Korean medicine in this population by analyzing medical records from 2 Korean medicine hospitals. A total of 54 patients were included. Demographic characteristics, growth-related indicators, seizure-related indicators, treatment patterns, follow-up duration, antiepileptic drug use, and adverse events were reviewed retrospectively. The mean age at seizure onset was 4.9 ± 4.9 years. Over a mean follow-up duration of 21.6 months, patients had an average of 10.2 ± 13.6 clinical visits and received heterogeneous treatment patterns, including herbal medicine decoction, herbal medicine formulation, and acupuncture. Mean height increased from 122.4 ± 27.6 to 134.0 ± 24.5 cm, and mean weight increased from 29.6 ± 22.1 to 34.9 ± 20.5 kg. Mean seizure frequency decreased from 0.7 ± 1.2 times per day at baseline to 0.2 ± 0.5 times per day during the follow-up period ( P = .002). Antiepileptic drug regimens remained largely unchanged during the study period among patients with available medication data. Mild adverse events were reported in 5 patients (nausea, abdominal pain, and diarrhea), all of which resolved without serious complications. This study provides real-world insights into the clinical use and tolerability of traditional Korean medicine treatment in pediatric and adolescent epilepsy. Although therapeutic efficacy cannot be established due to the absence of a control group, these findings offer foundational data to support future hypothesis-driven studies assessing the safety and potential effectiveness of traditional Korean medicine in this population.